CTKB
Price:
$6.55
Market Cap:
$843.71M
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for an...[Read more]
Industry
Medical - Devices
IPO Date
2021-07-23
Stock Exchange
NASDAQ
Ticker
CTKB
According to Cytek Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -81.87. This represents a change of -269.01% compared to the average of 48.44 of the last 4 quarters.
The mean historical PE Ratio of Cytek Biosciences, Inc. over the last ten years is 181.20. The current -81.87 PE Ratio has changed -4618.14% with respect to the historical average. Over the past ten years (40 quarters), CTKB's PE Ratio was at its highest in in the December 2021 quarter at 1.96K. The PE Ratio was at its lowest in in the March 2020 quarter at -664.24.
Average
181.20
Median
128.53
Minimum
-148.27
Maximum
533.13
Discovering the peaks and valleys of Cytek Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 284.48%
Maximum Annual PE Ratio = 533.13
Minimum Annual Increase = -186.69%
Minimum Annual PE Ratio = -148.27
Year | PE Ratio | Change |
---|---|---|
2023 | -101.56 | -119.05% |
2022 | 533.13 | 7.88% |
2021 | 494.18 | 284.48% |
2020 | 128.53 | -186.69% |
The current PE Ratio of Cytek Biosciences, Inc. (CTKB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
308.58
5-year avg
181.20
10-year avg
181.20
Cytek Biosciences, Inc.’s PE Ratio is less than Heska Corporation (-67.36), less than OrthoPediatrics Corp. (-21.46), less than Electromed, Inc. (39.44), less than Pulmonx Corporation (-4.67), less than RxSight, Inc. (-58.11), less than AxoGen, Inc. (-40.92), less than Treace Medical Concepts, Inc. (-7.92), less than Orthofix Medical Inc. (-6.11), less than NeuroPace, Inc. (-10.17), less than Inogen, Inc. (-4.23), less than Surmodics, Inc. (-48.35), less than Apyx Medical Corporation (-1.76), less than ProSomnus, Inc. Common Stock (-0.59), less than LivaNova PLC (117.78), less than Sight Sciences, Inc. (-4.01), less than STRATA Skin Sciences, Inc. (-1.31), less than Vapotherm, Inc. (-0.26), less than Talis Biomedical Corporation (-0.06),
Company | PE Ratio | Market cap |
---|---|---|
-67.36 | $1.31B | |
-21.46 | $637.85M | |
39.44 | $251.96M | |
-4.67 | $268.12M | |
-58.11 | $1.81B | |
-40.92 | $587.07M | |
-7.92 | $487.79M | |
-6.11 | $722.63M | |
-10.17 | $289.53M | |
-4.23 | $223.42M | |
-48.35 | $561.12M | |
-1.76 | $54.40M | |
-0.59 | $8.18M | |
117.78 | $2.79B | |
-4.01 | $203.53M | |
-1.31 | $12.72M | |
-0.26 | $13.55M | |
-0.06 | $3.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytek Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cytek Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cytek Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cytek Biosciences, Inc. (CTKB)?
What is the highest PE Ratio for Cytek Biosciences, Inc. (CTKB)?
What is the 3-year average PE Ratio for Cytek Biosciences, Inc. (CTKB)?
What is the 5-year average PE Ratio for Cytek Biosciences, Inc. (CTKB)?
How does the current PE Ratio for Cytek Biosciences, Inc. (CTKB) compare to its historical average?